Jarislowsky, Fraser LTD Gsk PLC Transaction History

Jarislowsky, Fraser LTD

$16.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$42.05 - $47.77 $1,051 - $1,194	-25 Reduced 0.11%	22,711 $988,000
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $83,115 - $98,630	-2,066 Reduced 8.33%	22,736 $990,000
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $46,656 - $54,372	-1,200 Reduced 4.62%	24,802 $1.09 Million
Q3 2021 Nov 12, 2021	SELL	$38.79 - $43.16 $279,288 - $310,752	-7,200 Reduced 21.69%	26,002 $993,000
Q2 2021 Aug 09, 2021	SELL	$36.52 - $41.46 $174,711 - $198,344	-4,784 Reduced 12.59%	33,202 $1.32 Million
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $695,509 - $812,002	-20,295 Reduced 34.82%	37,986 $1.36 Million
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $773,218 - $906,438	-22,695 Reduced 28.03%	58,281 $2.14 Million
Q3 2020 Nov 03, 2020	SELL	$38.11 - $42.99 $158,347 - $178,623	-4,155 Reduced 4.88%	80,976 $3.05 Million
Q2 2020 Aug 12, 2020	SELL	$37.87 - $43.58 $994,844 - $1.14 Million	-26,270 Reduced 23.58%	85,131 $3.47 Million
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $108,774 - $163,580	-3,350 Reduced 2.92%	111,401 $4.22 Million
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $384,048 - $441,198	-9,144 Reduced 7.38%	114,751 $5.39 Million
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $393,068 - $422,796	-9,715 Reduced 7.27%	123,895 $5.29 Million
Q2 2019 Aug 13, 2019	SELL	$39.4 - $42.7 $1.53 Million - $1.65 Million	-38,723 Reduced 22.47%	133,610 $5.35 Million
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $1.36 Million - $1.5 Million	-35,240 Reduced 16.98%	172,333 $7.2 Million
Q4 2018 Feb 01, 2019	SELL	$37.8 - $42.69 $648,837 - $732,773	-17,165 Reduced 7.64%	207,573 $7.93 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $2.13 Million - $2.29 Million	-53,705 Reduced 19.29%	224,738 $8.78 Million
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $997,775 - $1.08 Million	-25,190 Reduced 8.3%	278,443 $11.2 Million
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $2.87 Million - $3.19 Million	-79,397 Reduced 20.73%	303,633 $0
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $15.6 Million - $18.5 Million	-441,176 Reduced 53.53%	383,030 $0
Q3 2017 Nov 06, 2017	BUY	$39.44 - $41.55 $32.5 Million - $34.2 Million	824,206	824,206 $33.5 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account